ARTICLE | Company News
Kyowa Hakko Kirin sales and marketing update
December 22, 2014 8:00 AM UTC
Kyowa launched G-Lasta pegfilgrastim subcutaneous injection in Japan to decrease the incidence of chemotherapy-associated febrile neutropenia. The sustained-duration pegylated G-CSF is given once per...